296 results on '"Banya W"'
Search Results
2. P177 Cystic fibrosis (CF)-related complications and outcomes of women during pregnancy and post-partum in elexacaftor/tezacaftor/ivacaftor (ETI)-era
3. P178 Impact of pre-conception lung function in women with cystic fibrosis (wwCF) on obstetric and neonatal outcomes in the elexacaftor/tezacaftor/ivacaftor (ETI)-era
4. 1196 FRAILTY AND ARTERIAL STIFFNESS - THE ROLE OF OXIDATIVE STRESS AND INFLAMMATION (FRAXI STUDY)
5. S86 A single-blind, multicentre, multinational, randomised controlled trial of online singing for Lung Health (SLH) vs usual care for people with COPD: the Singing for Health, Improving Experiences of Lung Disease (SHIELD) Trial
6. PP312 [Heart » Heart]: NECROTISING ENTEROCOLITIS (NEC) IN CHILDREN WITH CONGENITAL HEART DISEASE ADMITTED TO A TERTIARY SPECIALIST CARDIAC PICU – INCIDENCE AND ASSOCIATIONS
7. Impact of an online breathing and wellbeing programme (ENO Breathe) in people with persistent symptoms following COVID-19: a randomised controlled trial
8. Comparative Effect of Lung volume reduction surgery for Emphysema and Bronchoscopic lung volume reduction with valve placement: the CELEB trial
9. Lipid-laden bronchoalveolar macrophages in asthma and chronic cough
10. Predictors of uptake of ambulatory oxygen on completion of the ambox trial, a study to assess effects of ambulatory oxygen on quality of life in patients with fibrotic interstitial lung disease: S57
11. P046 The effectiveness of CFTR modulators in people with cystic fibrosis and rare mutations – a real-world study
12. P201 Bowel screening for cancer in pre-transplant people with cystic fibrosis and the accuracy of faecal immunochemical testing
13. A retrospective analysis of the impact of azithromycin maintenance therapy on adults attending a UK cystic fibrosis clinic
14. Lung volume reduction surgeryversusendobronchial valves: a randomised controlled trial
15. Improved survival at low lung function in cystic fibrosis: cohort study from 1990 to 2007
16. Blood pressure control in the Hypertension in the Very Elderly Trial (HYVET)
17. Comparison between thromboelastography and conventional coagulation tests after cardiopulmonary bypass surgery in the paediatric intensive care unit
18. Reply to: one step at a time: a phased approach to behavioral treatment development in pulmonary rehabilitation
19. EPS4.10 Obstetric and neonatal outcomes in women with cystic fibrosis (wwCF) and diabetes in pregnancy
20. WS02.05 Obstetric and neonatal outcomes in cystic fibrosis (CF) show minimal variability with and without elexacaftor/tezacaftor/ivacaftor (ETI)
21. A quality assurance programme for cell salvage in cardiac surgery
22. Clinical characteristics and 28-day mortality of medical patients admitted with COVID-19 to a central London teaching hospital
23. S64 Use of pathological phenotype to determine optimal management for moderate to severe preschool wheeze
24. Asthma, smoking and chronic cough in rural and urban adult communities in The Gambia
25. Atopy, intestinal helminth infection and total serum IgE in rural and urban adult Gambian communities
26. The CELEB trial: Comparative effectiveness of lung volume reduction surgery for emphysema and bronchoscopic lung volume reduction with valve placement. A protocol for a randomised controlled trial
27. Safety and efficacy of levosimendan in a cardiothoracic ICU – 5 year data
28. A Video Intervention to Increase Pulmonary Rehabilitation Uptake for Patients Hospitalized with Acute Exacerbations of COPD (virtue): A Randomized Controlled Trial
29. G197(P) Perinatal management of major structural congenital cardiac defects as guided by fetal echocardiography
30. T5 Oral dietary nitrate supplementation to enhance pulmonary rehabilitation in chronic obstructive pulmonary disease: a multi-centre, double blind, placebo-controlled, parallel group study
31. Carriage of pneumococci after pneumococcal vaccination
32. CELEB trial: Comparative Effectiveness of Lung volume reduction surgery for Emphysema and Bronchoscopic lung volume reduction with valve placement: a protocol for a randomised controlled trial
33. Can we predict Veno-Venous extra-corporeal membrane oxygenation duration?
34. Are Risk Scores Applicable in Tertiary Veno-Venous Extra-Corporeal Membrane Oxygenation Centers?
35. Apheresis as novel treatment for refractory angina with raised lipoprotein(a): a randomised controlled trial
36. Pedometer step count targets during pulmonary rehabilitation in COPD: a randomized controlled trial
37. P5436Does cardiac rehabilitation improve functional, independence, frailty and emotional outcomes following trans catheter aortic valve replacement?
38. S57 Predictors of uptake of ambulatory oxygen on completion of the ambox trial, a study to assess effects of ambulatory oxygen on quality of life in patients with fibrotic interstitial lung disease
39. Quantitative association tests of immune responses to antigens of Mycobacterium tuberculosis: a study of twins in West Africa
40. Should we abandon the APTT for monitoring unfractionated heparin?
41. EPS7.10 Clinical benefit of continuous nebulised Aztreonam Lysine for Inhalation (AZLI) in adults with cystic fibrosis – a retrospective cohort study
42. The effect of patient and centre characteristics on the outcome of a multi-faceted quality Improvement programme
43. 7 The impact of in-situ simulation training on individual and team performance during real cardiopulmonary resuscitations on a paediatric intensive care unit (picu)
44. The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart Study
45. The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart Study
46. P56 Cross-sectional study of prevalence of sensitisation to mouse allergens in laboratory animal workers: the SPIRAL (Safe Practice In Reducing Allergy in Laboratories) study
47. P53 Determination of specific IgE antibodies to mouse proteins in laboratory animal workers: Abstract P53 Table 1
48. The impact of depressive symptoms on recovery and outcome of hospitalised COPD exacerbations
49. Moderated Poster Session 4: Monday 4 May 2015, 15:30-16:30 * Room: Moderated Poster Area
50. is augmentation index a good measure of vascular stiffness in the elderly?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.